ProQR Therapeutics (PRQR) Cash from Operations Growth (3y) (2016 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2.78% |
| Sep 30, 2022 | -16.64% |
| Jun 30, 2022 | -9.02% |
| Mar 31, 2022 | -17.80% |
| Dec 31, 2021 | 648.13% |
| Sep 30, 2021 | -24.27% |
| Jun 30, 2021 | -22.90% |
| Mar 31, 2021 | -10,494.74% |
| Dec 31, 2020 | -1,010.09% |
| Sep 30, 2020 | -10,762.67% |
| Jun 30, 2020 | -2.19% |
| Mar 31, 2020 | -55.64% |
| Dec 31, 2019 | 28.96% |
| Sep 30, 2019 | -832.26% |
| Dec 31, 2018 | 92.68% |
| Sep 30, 2018 | -792.39% |
| Mar 31, 2018 | 25.99% |
| Dec 31, 2017 | 26.03% |
| Sep 30, 2017 | 25.99% |
| Mar 31, 2017 | 26.07% |
| Dec 31, 2016 | -208.15% |
| Sep 30, 2016 | 77.28% |